People with multiple sclerosis (MS) who have mild disability still experience several disease-related difficulties at work — challenges that…
Articles by Marisa Wexler, MS
A group of international experts has proposed a first-of-its-kind framework aimed at preventing multiple sclerosis (MS) from developing. Rather…
Inflammatory gut bacteria that carry proteins structurally similar to myelin, a protective layer surrounding nerve fibers that is damaged in…
Multiple sclerosis (MS) may follow two distinct biological paths that differ in how early and how quickly nerve damage…
The balance between two immune signaling molecules — CXCL13 and BAFF — may help identify the hard-to-treat inflammation in the…
The National Institute for Health and Care Excellence (NICE) in England is recommending natalizumab — sold as Tysabri and…
Quantum Biopharma has completed dosing in two toxicology studies requested by the U.S. Food and Drug Administration (FDA) that…
Throughout 2025, the team at Multiple Sclerosis News Today brought our readers the latest advances and updates in research related…
After months of delay, the U.S. Food and Drug Administration (FDA) has rejected Sanofi‘s application seeking approval of…
Disability progression in relapsing forms of multiple sclerosis (MS) tends to follow one of four distinct patterns, according to…
Myelin, the protective coating that helps nerve signals travel quickly and efficiently, also plays a key role in the precise…
A clinical trial testing whether music therapy can make botulinum toxin injections for spasticity more tolerable for people with…
Following negative Phase 3 trial results, Sanofi announced that it will not be pursuing approval of its experimental therapy…
A signaling molecule called erythropoietin (EPO) plays a key role in allowing the immune system to distinguish the body’s own…
A few months ago in Barcelona, at the annual conference of the European Committee for Treatment and Research in Multiple…
Disability progression is not always permanent for people with relapsing-remitting multiple sclerosis (RRMS), even when it occurs independent of…
Oligodendrocytes, the cells that build and repair myelin in the brain and spinal cord, may play a role in the…
Simultaneously measuring levels of two blood proteins — glial fibrillary acidic protein (GFAP) and neurofilament light chain (NfL)…
A Phase 2 clinical trial testing PIPE-307, an experimental therapy designed to support myelin repair in people with multiple…
A clinical trial is now recruiting participants to test whether an experimental vaccine for the Epstein-Barr virus (EBV) is…
Mesenchymal stem cell therapy shows promise for treating multiple sclerosis (MS), with improvements seen in disability, walking ability,…
A new technique is letting scientists peer into the brain’s wiring with greater detail by simply using a microscope and…
Genentech‘s experimental oral therapy fenebrutinib has become the first Bruton’s tyrosine kinase (BTK) inhibitor to show positive Phase…
A new wearable brain-mapping tool could dramatically change how doctors monitor people with multiple sclerosis (MS), making it easier…
Researchers have developed a highly sensitive imaging technique that can detect damage to myelin, the fatty wrapping around nerve…
Ultraviolet light therapy may help reduce inflammation and disease severity in people with multiple sclerosis (MS), according to data…
People with multiple sclerosis (MS) tend to have high levels of antibodies targeting the Epstein-Barr virus (EBV), but…
People living with multiple sclerosis (MS) have consistently lower quality of life than the general population — regardless of…
A third of adults live with chronic physical conditions such as multiple sclerosis (MS), but in most cases these…
Eating more carbohydrates is significantly associated with a higher risk of developing multiple sclerosis (MS), particularly among women and…